Healthcare Reports and Subscriptions

This report serves as both a primer into the field of digital health, summarizing the findings across telehealth/telemedicine, remote patient monitoring (including diabetes management technologies), digital therapeutics, consumer health wearables, and AI in medical imaging diagnostics. The report provides profiles of over 135 companies active in the field, a detailed 10-year forecast of over 19 types of RPM technologies, and a 40-year outlook on the uptake of AI in imaging diagnostics across 13 therapeutic areas.

This report covers the antimicrobial technology market, including analysis of four key antimicrobial technologies: silver, copper, zinc and silane quaternary compounds. Antimicrobial technologies provide residual protection against microbes. The report examines how the technologies work, key considerations for companies seeking to develop products, and analyzes over 100 companies active in this area.

This report characterizes the electronic skin patches markets, technologies, and players. Coverage across 13 electronic skin patch application areas, historic market data from 2010-2022 and market forecasts from 2023 to 2033, it is the most comprehensive study compiled for this product area. It reveals significant opportunity, with the electronic skin patch market forecast to grow to over $27bn by 2033.

Remote patient monitoring (RPM), the use of technology to measure and transmit physiologic data beyond traditional healthcare settings, has risen in prominence since the COVID-19 pandemic. In this report IDTechEx covers connected medical devices such as blood pressure cuffs, ambulatory cardiac monitors, and continuous glucose monitors in RPM applications in cardiovascular disease, diabetes, respiratory, and general health and wellness. Ten-year market forecasts to 2033 cover 19 product categories.

This report covers the DNA sequencing industry, discussing the key technologies and markets involved. The report covers Sanger, Next-Generation (NGS), and nanopore sequencing, benchmarking these against each other on key metrics required by leading applications. The report includes in-depth analyses of DNA sequencing applications ranging from population genomics and companion diagnostics to forensics, identifying the requirements for each. Barriers of entry to the market and relevant challenges are analysed.

This report covers the entire landscape for diabetes management devices, including mature, emerging, and future options. We characterise and predict the technological landscape of the industry over the next decade. Strategies of major players in the industry are discussed and analysed. Developments of major milestones, such as the launch of closed-loop systems and non-invasive CGMs, are considered and discussed in our forecasts.

Point-of-care biosensors have been crucial in handling the COVID-19 pandemic, which has caused the market to more than double since 2019. In this report IDTechEx explores the drivers of the market's growth, key technologies enabling point-of-care testing, assesses emerging technologies bringing patient diagnosis ever closer to the point-of-care, and the opportunities and threats that these trends present.

Artificial intelligence (AI) is emerging as a technology that can solve longstanding problems in drug development, including drug discovery. This report highlights the key machine learning and deep learning technologies (architectures and algorithms), companies, and applications driving billion-dollar investments and deals between the biopharma industry and AI drug discovery start-ups. AI will significantly accelerate drug discovery timelines and introduce substantial cost savings for the biopharma industry.

This report explores the field of image recognition artificial intelligence (AI) for disease detection by breaking down its five main clinical applications. It describes emerging technologies, highlights key players and analyses market landscape for each sector. Trends, opportunities, threats and challenges (both technical and commercial) are discussed at length, thereby providing detailed insights into the current and future market for this technology.

This report covers the techniques and technologies used to quantitatively measure and analyze skin parameters for the cosmetics industry. Recent developments in electronics and changes in consumer behaviour are accelerating broader uptake of skin sensors. The market for skin sensors in the cosmetics industry is forecast to reach $275 million by the year 2030, driven by skin care companies seeking solutions in e-commerce, smart retail, hyper personalized skin care and more.

This report covers the latest applications of flexible electronics in healthcare, including electronic skin patches, electronic textiles, electrochemical test strips and smart blister packs. With increasing decentralization in the healthcare system enabled by the digital health movement, flexible electronics is well positioned to provide comfortable and long-term remote patient monitoring solutions. Flexible electronics enable new form factors and new products in health monitoring, a significant market worth over $8.3 billion in 2030.

The market for advanced wound care technologies is forecast to exceed $22 billion by the year 2030, driven mainly by the increase in demand by aging populations and the increasing prevalence of diabetes worldwide. With this increasing burden on healthcare systems around the world, advanced wound care products will focus on improving the wound care patient pathway and increasing the cost effectiveness of treatments.